Patent · US Active

Naphthyridinone derivatives for the treatment of a disease or disorder

US12084442B2 · kind B2 · utility

0Cited by

0References

21Claims

0Family size

Assignee

Novartis AG · CH

Inventors

Atwood Kim CHEUNG · Arlington, US
Donglei Liu · Cambridge, US
Stefan Peukert · Frankfurt am Main, DE
Heng GE · 安丰镇, CN
Yu Gai · Hoherlehmer Straße, CN
Xingjuan CHANG · 安丰镇, CN

Key dates

Filing date	Nov 21, 2022
Grant date	Sep 10, 2024
Priority date	—
Expiry date	Nov 21, 2042

Classification

Technology area (CPC A)Human Necessities
CPC primaryA61P9/00
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

The invention relates to a compound of formula (I): or a pharmaceutically acceptable salt thereof, wherein A, R1 and R3 are as described herein, as well as compositions and methods of using such compounds.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.